Century Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Century Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-68,155	Closed	-$9.05M	–	232
2015 Q3	$9.05M	Hold	68,155	–	–	0.51%	68
2015 Q2	$12M	Sell	68,155 -3,649	-5%	-$655K	0.68%	52
2015 Q1	$12.4M	Sell	71,804 -5,271	-7%	-$905K	0.71%	51
2014 Q4	$12.6M	Buy	77,075 +13,645	+22%	+$2.26M	0.73%	52
2014 Q3	$10.2M	Sell	63,430 -9,986	-14%	-$1.54M	0.6%	58
2014 Q2	$10.8M	Sell	73,416 -55,408	-43%	-$7.68M	0.57%	59
2014 Q1	$17.9M	Sell	128,824 -323,107	-71%	-$48.6M	0.83%	47
2013 Q4	$57.2M	Sell	451,931 -106,082	-19%	-$11M	2.29%	2
2013 Q3	$51.3M	Sell	558,013 -171,981	-24%	-$13.9M	2.14%	2
2013 Q2	$50.2M	Buy	+729,994	New	+$44.6M	1.97%	3

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Herndon Capital Management Atlanta, Georgia $659M AUM 22.02% 1-Year Est. Return

Century Capital Management's JAZZ Position: Q4 2015 in Review

Century Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2015, closing a stake of 68,155 shares — an estimated $9.05M sold.

Century Capital Management first reported a position in JAZZ in Q2 2013 and held it in 10 quarters. The position peaked at $57.2M in Q4 2013. 345 funds tracked by Wall St. Rank hold JAZZ as of Q4 2015.

Century Capital Management reported no remaining Jazz Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Century Capital Management sold 68,155 Jazz Pharmaceuticals shares in Q4 2015, an estimated $9.05M.
Century Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 10 quarters.
Century Capital Management's Jazz Pharmaceuticals position peaked at $57.2M in Q4 2013.
345 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2015.

Based on Century Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.